Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lord

Showing results (261-270 of 594) with videos related to

Pageof 60
Sort By:
Drugs in R&D|March 18, 2006
Effect of a novel molybdenum ascorbate complex on ex vivo myocardial performance in chemical diabetes mellitusTom L Broderick, John Bailey, Karen J Gagnon, et al.
The Medical Journal of Australia|November 9, 2005
A systematic review and economic analysis of drug-eluting coronary stents available in AustraliaSarah J Lord, Kirsten Howard, Felicity Allen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2008
Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancerNehmat Houssami, Stefano Ciatto, Petra Macaskill, et al.
The EMBO Journal|February 2, 2012
APRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancerRachel Brough, Ilirjana Bajrami, Radost Vatcheva, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|February 24, 2001
The murine type 1 diabetes loci, Idd1, Idd3, Idd5, Idd9, and Idd17/10/18, do not control thymic CD4-CD8-/TCRalphabeta+ deficiency in the nonobese diabetic mouseC J Lord, S Howlett, P A Lyons, et al.
British Journal of Cancer|April 15, 2010
Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancerC K Lee, M R Stockler, A S Coates, et al.
The Cochrane Database of Systematic Reviews|November 29, 2024
Molecular biomarkers for predicting complete response to preoperative chemoradiation in people with locally advanced rectal cancerPenelope A De Lacavalerie, Sarah J Lord, Matthew J Morgan, et al.
Diseases of the Nervous System|April 1, 1977
Acute schizophrenia: an efficacious outpatient treatment approach as an alternative to full-time hospitalizationA J Levenson, C J Lord, C E Sermas, et al.
Oncotarget|January 8, 2015
The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate notch signallingNeil Rajan, Richard J R Elliott, Alice Smith, et al.
Plos One|July 27, 2018
Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016)Benjamin Daniels, Federico Girosi, Hanna Tervonen, et al.
Pageof 60

Showing results (261-270 of 594) with videos related to

Sort By:
Pageof 60
Drugs in R&D|March 18, 2006
Effect of a novel molybdenum ascorbate complex on ex vivo myocardial performance in chemical diabetes mellitusTom L Broderick, John Bailey, Karen J Gagnon, et al.
The Medical Journal of Australia|November 9, 2005
A systematic review and economic analysis of drug-eluting coronary stents available in AustraliaSarah J Lord, Kirsten Howard, Felicity Allen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2008
Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancerNehmat Houssami, Stefano Ciatto, Petra Macaskill, et al.
The EMBO Journal|February 2, 2012
APRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancerRachel Brough, Ilirjana Bajrami, Radost Vatcheva, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|February 24, 2001
The murine type 1 diabetes loci, Idd1, Idd3, Idd5, Idd9, and Idd17/10/18, do not control thymic CD4-CD8-/TCRalphabeta+ deficiency in the nonobese diabetic mouseC J Lord, S Howlett, P A Lyons, et al.
British Journal of Cancer|April 15, 2010
Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancerC K Lee, M R Stockler, A S Coates, et al.
The Cochrane Database of Systematic Reviews|November 29, 2024
Molecular biomarkers for predicting complete response to preoperative chemoradiation in people with locally advanced rectal cancerPenelope A De Lacavalerie, Sarah J Lord, Matthew J Morgan, et al.
Diseases of the Nervous System|April 1, 1977
Acute schizophrenia: an efficacious outpatient treatment approach as an alternative to full-time hospitalizationA J Levenson, C J Lord, C E Sermas, et al.
Oncotarget|January 8, 2015
The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate notch signallingNeil Rajan, Richard J R Elliott, Alice Smith, et al.
Plos One|July 27, 2018
Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016)Benjamin Daniels, Federico Girosi, Hanna Tervonen, et al.
Pageof 60